Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
AIG
|
W Don Cornwell
Director |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 60.0% |
$88,905
$59.27 p/Share
|
Feb 27
2018 |
|
HWC
|
Michael M Achary
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 12,519 Reduced 25.74% |
$668,515
$53.4 p/Share
|
Feb 27
2018 |
|
CB
|
Juan C Andrade
Executive Vice President* |
SELL
Payment of exercise price or tax liability
|
Direct | 707 Reduced 0.62% |
$101,942
$144.19 p/Share
|
Feb 27
2018 |
|
CB
|
Philip V Bancroft
Executive Vice President* |
SELL
Payment of exercise price or tax liability
|
Direct | 559 Reduced 0.16% |
$80,602
$144.19 p/Share
|
Feb 27
2018 |
|
CB
|
Timothy Alan Boroughs
Executive Vice President* |
SELL
Payment of exercise price or tax liability
|
Direct | 610 Reduced 0.31% |
$87,956
$144.19 p/Share
|
Feb 27
2018 |
|
CB
|
John W Keogh
President & COO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,087 Reduced 0.42% |
$156,735
$144.19 p/Share
|
Feb 27
2018 |
|
CB
|
Evan G Greenberg
Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,645 Reduced 0.18% |
$381,383
$144.19 p/Share
|
Feb 27
2018 |
|
CB
|
John J Lupica
Vice Chrm, Chubb Group* |
SELL
Payment of exercise price or tax liability
|
Direct | 1,164 Reduced 0.6% |
$167,837
$144.19 p/Share
|
Feb 27
2018 |
|
CB
|
Paul Bennett Medini
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 512 Reduced 0.58% |
$73,825
$144.19 p/Share
|
Feb 27
2018 |
|
CB
|
Joseph F Wayland
Executive Vice President and* |
SELL
Payment of exercise price or tax liability
|
Direct | 297 Reduced 0.38% |
$42,824
$144.19 p/Share
|
Feb 27
2018 |
|
AMZN
|
Jeffrey P Bezos
Executive Chair |
SELL
Bona fide gift
|
Direct | 66 Reduced 0.0% |
-
|
Feb 27
2018 |
|
AMZN
|
Jeffrey A Wilke
CEO Worldwide Consumer |
SELL
Open market or private sale
|
Indirect | 1,550 Reduced 0.34% |
$2,352,667
$1517.85 p/Share
|
Feb 27
2018 |
|
CHCO
|
Charles R Hageboeck
President & CEO |
SELL
Open market or private sale
|
Direct | 1,593 Reduced 2.05% |
$111,112
$69.75 p/Share
|
Feb 27
2018 |
|
AMT
|
James D Taiclet Jr |
BUY
Grant, award, or other acquisition
|
Direct | 15,860 Added 8.01% |
-
|
Feb 27
2018 |
|
AMT
|
Thomas A Bartlett |
BUY
Grant, award, or other acquisition
|
Direct | 6,468 Added 5.3% |
-
|
Feb 27
2018 |
|
AMT
|
William H Hess |
BUY
Grant, award, or other acquisition
|
Direct | 6,468 Added 5.76% |
-
|
Feb 27
2018 |
|
AMT
|
Edmund Di Santo |
BUY
Grant, award, or other acquisition
|
Direct | 6,116 Added 3.97% |
-
|
Feb 27
2018 |
|
AMT
|
Steven C. Marshall
Former Officer |
BUY
Grant, award, or other acquisition
|
Direct | 6,468 Added 5.75% |
-
|
Feb 27
2018 |
|
AMT
|
Amit Sharma
Spl. Adv. to CEO & Chm. APAC |
BUY
Grant, award, or other acquisition
|
Direct | 5,374 Added 3.87% |
-
|
Feb 27
2018 |
|
LMT
|
John Frank A St
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 74.66% |
$540,825
$360.55 p/Share
|
Feb 27
2018 |
|
CVS
|
Eva C Boratto
EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 197 Reduced 0.5% |
$13,445
$68.25 p/Share
|
Feb 27
2018 |
|
TMO
|
Michel Lagarde
Executive Vice President & COO |
BUY
Grant, award, or other acquisition
|
Direct | 2,200 Added 4.25% |
-
|
Feb 27
2018 |
|
TMO
|
Stephen Williamson
Sr. VP and CFO |
BUY
Grant, award, or other acquisition
|
Direct | 13,700 Added 23.81% |
-
|
Feb 27
2018 |
|
TMO
|
Stephen Williamson
Sr. VP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 881 Reduced 2.01% |
$185,609
$210.68 p/Share
|
Feb 27
2018 |
|
TMO
|
Mark Stevenson
Retiring Executive VP & COO |
BUY
Grant, award, or other acquisition
|
Direct | 24,300 Added 21.84% |
-
|
Feb 27
2018 |
|
TMO
|
Mark Stevenson
Retiring Executive VP & COO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,568 Reduced 2.95% |
$541,026
$210.68 p/Share
|
Feb 27
2018 |
|
TMO
|
Peter E Hornstra
VP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 775 Added 4.03% |
-
|
Feb 27
2018 |
|
TMO
|
Peter E Hornstra
VP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 38 Reduced 0.21% |
$8,006
$210.68 p/Share
|
Feb 27
2018 |
|
TMO
|
Seth H Hoogasian
Sr. VP & Retiring Gen. Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 6,203 Added 16.55% |
-
|
Feb 27
2018 |
|
TMO
|
Seth H Hoogasian
Sr. VP & Retiring Gen. Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 2,273 Reduced 7.27% |
$478,876
$210.68 p/Share
|
Feb 27
2018 |
|
TMO
|
Patrick M Durbin
Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 11,300 Added 22.88% |
-
|
Feb 27
2018 |
|
TMO
|
Patrick M Durbin
Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 678 Reduced 1.78% |
$142,841
$210.68 p/Share
|
Feb 27
2018 |
|
TMO
|
Michael A Boxer
SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 1,200 Added 32.26% |
-
|
Feb 27
2018 |
|
TMO
|
Marc N Casper
Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 58,900 Added 16.13% |
-
|
Feb 27
2018 |
|
TMO
|
Marc N Casper
Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 5,912 Reduced 1.93% |
$1,245,540
$210.68 p/Share
|
Feb 27
2018 |
|
MRK
|
Adam H Schechter
EVP & Pres-Global Human Health |
BUY
Grant, award, or other acquisition
|
Direct | 34,094 Added 50.0% |
$1,865,624
$54.72 p/Share
|
Feb 27
2018 |
|
MRK
|
Kenneth C Frazier
Executive Chair |
BUY
Grant, award, or other acquisition
|
Direct | 110,393 Added 13.44% |
$6,040,705
$54.72 p/Share
|
Feb 27
2018 |
|
MRK
|
Roger M Perlmutter
Exe V-P & Pres, MRL |
BUY
Grant, award, or other acquisition
|
Direct | 34,931 Added 20.09% |
$1,911,424
$54.72 p/Share
|
Feb 27
2018 |
|
MRK
|
Ashley Watson
SVP Chief Ethics & Com Officer |
BUY
Grant, award, or other acquisition
|
Direct | 2,322 Added 50.0% |
$127,060
$54.72 p/Share
|
Feb 27
2018 |
|
MRK
|
Weir Mirian M Graddick
Exe V-P, HR |
BUY
Grant, award, or other acquisition
|
Direct | 13,949 Added 11.78% |
$763,289
$54.72 p/Share
|
Feb 27
2018 |
|
MRK
|
Sanat Chattopadhyay
Exe V-P & Pres. MMD |
BUY
Grant, award, or other acquisition
|
Direct | 4,522 Added 8.58% |
$247,444
$54.72 p/Share
|
Feb 27
2018 |
|
MRK
|
Julie L. Gerberding
EVP, Chief Patient Officer |
BUY
Grant, award, or other acquisition
|
Direct | 9,062 Added 14.08% |
$495,873
$54.72 p/Share
|
Feb 27
2018 |
|
MRK
|
Richard R. De Luca
EVP&Pres, Merck Animal Heallth |
BUY
Grant, award, or other acquisition
|
Direct | 12,575 Added 18.5% |
$688,104
$54.72 p/Share
|
Feb 27
2018 |
|
MRK
|
Michael J Holston
EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 20,694 Added 22.87% |
$1,132,376
$54.72 p/Share
|
Feb 27
2018 |
|
MRK
|
Robert M Davis
Chairman, CEO & President |
BUY
Grant, award, or other acquisition
|
Direct | 30,908 Added 22.55% |
$1,691,286
$54.72 p/Share
|
Feb 27
2018 |
|
MRK
|
Rita A Karachun
Sr. VP Fince-Global Controller |
BUY
Grant, award, or other acquisition
|
Direct | 3,090 Added 13.86% |
$169,085
$54.72 p/Share
|
Feb 27
2018 |
|
HD
|
Edward P. Decker
Chair, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 17,660 Added 19.31% |
$411,125
$23.28 p/Share
|
Feb 27
2018 |
|
HD
|
Edward P. Decker
Chair, President and CEO |
SELL
Open market or private sale
|
Direct | 17,660 Reduced 23.92% |
$3,308,071
$187.32 p/Share
|
Feb 27
2018 |
|
HGEN
|
Dale Chappell
Chief Scientific Officer |
BUY
Other acquisition or disposition
|
Indirect | 29,893,424 Added 46.16% |
-
|
Feb 27
2018 |
|
HGEN
|
Dale Chappell
Chief Scientific Officer |
BUY
Open market or private purchase
|
Indirect | 32,028,669 Added 40.59% |
$2,882,580
$0.09 p/Share
|
Feb 27
2018 |